During the past decade, convincing evidence has accumulated that conquering heart disease is not simply a matter of driving serum cholesterol to lower and lower levels; in fact, half the people who have a heart attack have normal cholesterol. Newer research has thrown into question the primacy of elevated LDL cholesterol as the primary driver of heart disease. It appears that cholesterol, while an important signpost, is but one of a variety of markers that indicate cardiovascular risk. “Distinguishing between risk factors and causes is necessary for effective primary prevention and treatment of chronic disease… Risk factor treatment must be replaced with elimination of the drivers, triggers, and causes of chronic disease.”1
IFM’s Cardiometabolic Advanced Practice Module:
The module will help clinicians understand the foundational biology of cardiometabolic syndrome, the state of the evidence for a new perspective on the model, which assessment and treatment applications are ready for patient care, and how to integrate them into an active practice.
1 Hyman MA. The failure of risk factor treatment for primary prevention of chronic disease. Altern Ther Health Med. 2010;16(3):60-63.